Tranlisant en es it fr

Tranlisant Brand names, Tranlisant Analogs

Tranlisant Brand Names Mixture

  • No information avaliable

Tranlisant Chemical_Formula


Tranlisant RX_link

No information avaliable

Tranlisant fda sheet

Tranlisant msds (material safety sheet)

Tranlisant Synthesis Reference

No information avaliable

Tranlisant Molecular Weight

309.469 g/mol

Tranlisant Melting Point

< 25 oC

Tranlisant H2O Solubility

Soluble as HCl salt

Tranlisant State


Tranlisant LogP


Tranlisant Dosage Forms

Tablets (oral, 1 mg)

Tranlisant Indication

Used for the symptomatic treatment of parkinsonism.

Tranlisant Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Tranlisant Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Tranlisant side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Tranlisant Patient Information

Tranlisant Organisms Affected

Humans and other mammals